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Abstract
High proportions of autistic children suffer from gastrointestinal (GI) disorders, implying a link between autism and
abnormalities in gut microbial functions. Increasing evidence from recent high-throughput sequencing analyses indicates
that disturbances in composition and diversity of gut microbiome are associated with various disease conditions. However,
microbiome-level studies on autism are limited and mostly focused on pathogenic bacteria. Therefore, here we aimed to
define systemic changes in gut microbiome associated with autism and autism-related GI problems. We recruited 20
neurotypical and 20 autistic children accompanied by a survey of both autistic severity and GI symptoms. By
pyrosequencing the V2/V3 regions in bacterial 16S rDNA from fecal DNA samples, we compared gut microbiomes of GI
symptom-free neurotypical children with those of autistic children mostly presenting GI symptoms. Unexpectedly, the
presence of autistic symptoms, rather than the severity of GI symptoms, was associated with less diverse gut microbiomes.
Further, rigorous statistical tests with multiple testing corrections showed significantly lower abundances of the genera
Prevotella, Coprococcus, and unclassified Veillonellaceae in autistic samples. These are intriguingly versatile carbohydrate-
degrading and/or fermenting bacteria, suggesting a potential influence of unusual diet patterns observed in autistic
children. However, multivariate analyses showed that autism-related changes in both overall diversity and individual genus
abundances were correlated with the presence of autistic symptoms but not with their diet patterns. Taken together, autism
and accompanying GI symptoms were characterized by distinct and less diverse gut microbial compositions with lower
levels of Prevotella, Coprococcus, and unclassified Veillonellaceae.
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Introduction
Autism Spectrum Disorders (ASD) are complex neurobiological
disorders whose chief manifestations are qualitative impairment in
social interaction and communication and restricted, repetitive,
and stereotyped patterns of behavior, interests, and activities [1].
There is a world-wide increase in the diagnosis of ASD, which has
reached an epidemic level [2]. ASD patients and their families face
difficulties in treatment due to a highly diverse etiology of ASD in
which genetic and environmental factors are equally important, as
implied by a large twin concordance study [3]. One potentially
important environmental factor is abnormal intestinal flora. A
large fraction of autistic children suffer from gastrointestinal (GI)
problems, and a strong positive correlation was observed between
GI problems and ASD severity [4]. Up to 1014 bacteria in human
intestine balance the immune system, help digestion, produce
vitamins, and promote GI motility [5]. Several studies have
reported an increased administration of oral antibiotics to autistic
children during the first 3 years of life [6–8], which may destabilize
microbial community by eliminating beneficial bacteria and
helping pathogenic bacteria colonize the intestinal walls [9]. In
addition, considering the potential interactions between intestinal
microbes and the central nervous system [10], abnormal intestinal
flora may be associated not only with GI problems but also with
ASD-related behavioral symptoms.
Potential involvement of gut microbes in ASD etiology has been
speculated for more than a decade. Many pathogenic gram-
negative bacteria contain lipopolysaccharide (LPS) in their cell
walls, which can cause damage in various tissues including the
brain [11]. LPS-induced inflammation in the brain increases
permeability of the blood-brain barrier and facilitates an
accumulation of high levels of mercury in cerebrum, which may
aggravate ASD symptoms [6]. A test in rats showed that prenatal
LPS exposure decreased levels of glutathione [12], which is an
important antioxidant involved in heavy metal detoxification in
the brain. The down-regulated synthesis of glutathione may
increase the vulnerability of children to ASD and other neurologic
disorders, such as Friedreich’s Ataxia [13]. Indeed, a recent
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pyrosequencing analysis showed that gram-negative bacteria,
Desulfovibrio and Bacteroides vulgatus, were detected at higher levels
in autistic children [14]. On the other hand, Clostridium, a gram
positive bacterium, has also been widely studied in the context of
ASD [15,16] because it produces exotoxins and propionate. In a
study on rats which was recently reported, propionate worsened
ASD-like behavior [17]. In addition, Clostridium difficile produces p-
cresol, which can cause depletion of glutathione [18]. Vancomycin
and ampicillin, antibiotics targeting cell wall damage, significantly
affect the physiology and structure of gut microbiota; especially on
gram-positive bacteria such as Clostridium difficile [19]. One study
showed that in a small scale clinical setting, vancomycin treatment
resulted in temporary improvement of autistic symptoms in
children with late-onset autism [20].
Despite the importance of community-wide balance in main-
taining healthy gut flora, there have been limited efforts to
investigate gut microbiota as a functionally interconnected
microecosystem in relation to autism. Moreover, previous studies
describing the relationship between autism and gut microbes have
either mostly focused on the emergence of harmful bacteria or
mainly paid attention to already-known beneficial bacteria, such as
Bifidobacteria and Lactobacillus [4,14,21]. In this study, we collected
data on relative abundances of intestinal bacteria from neuroty-
pical and autistic children by 454 Titanium pyrosequencing, and
investigated systemic differences in their microbiome. Our
comprehensive bioinformatics and statistical analyses demonstrat-
ed that autistic children have a distinct and less diverse gut
microbial community structure, which can be characterized by
lower levels of a group of distinctive bacterial genera.
Materials and Methods
Ethics Statement
The Institutional Review Board (IRB) at Arizona State
University approved the study (ASU IRB Protocol #:
1004005109). People who expressed interest in joining our study
were mailed a written consent form and initial questionnaires
(Participation questionnaire and GI severity index form) to
complete and return to us. Once we received written informed
consent forms (signed by parents or guardians) and complete
questionnaires, we mailed sample collection kits to prospective
participants.
Subject Recruitment and Sample Collection
We recruited 20 neurotypical children and 20 children with
ASD. The enrolled subjects were between the ages of 3 and 16
years and did not use any type of antibiotic or antifungal
medications at least within one month prior to sample collection.
We assessed the GI symptoms of the children with a modified
version of the GSI questionnaire [22]. Children with ASD were
assessed with the Autism Diagnostics Interview – Revised (ADI-
Revised), Autism Diagnostics Observation Schedule (ADOS),
Autism Treatment Evaluation Checklist (ATEC), and Pervasive
Developmental Disorder Behavior Inventory (PDD-BI) to ensure
that they had a diagnosis of autism. We also conducted surveys
documenting some of their diet patterns, such as: gluten-free/
casein-free (GF/CF) diet, probiotics use, seafood consumption,
and usage of nutrient supplements (e.g., vitamins/calcium).
Detailed information on the survey can be found in the Supporting
Information (Text S1).
Sample collection and DNA extraction. Parents collected
and froze a single fecal sample from each subject. Frozen fecal
samples were shipped overnight to Arizona State University with a
cold pack, and stored in 280uC until DNA extraction. In order to
target DNA that was heterogeneously distributed in stool samples,
we followed the protocol recommended by QIAamp (Qiagen, CA)
DNA Stool Mini Kit (Protocol: Isolation of DNA from larger
volumes of stool). We first collected one gram (wet weight) of stool
sample per extraction, added 10 ml ASL lysis buffer solution, and
vortexed it vigorously until the stool sample was thoroughly
homogenized. Then, we used 2 ml of the lysate and followed the
manufacturer’s recommendations. We assessed the quantity and
quality of DNA by measuring absorbance at 260 and 280 nm
using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technology, Rockland, DE). Before we sent genomic DNA
samples to the sequencing facility for pyrosequencing, we
confirmed PCR amplification with universal bacterial primers
[23], and ran agarose gel (1%, w/v) electrophoresis to confirm the
efficiency of PCR amplification visually.
Pyrosequencing Analysis of Community Structures
We sent extracted genomic DNA to the Research and Testing
Laboratory (Lubbock, TX, USA), where the bacterial tag-encoded
FLX amplicon pyrosequencing (bTEFAP) was performed by the
Genome Sequencer FLX-Titanium System and its Titanium
protocol (Roche, Indianapolis, IN) as described [24]. We targeted
V2 and V3 regions of 16S rDNA for pyrosequencing by selecting
bacterial primers 104F (59-GGCGVACGGGTGAGTAA-39) and
530R (59-CCGCNGCNGCTGGCAC-39). We denoised PCR
artifacts by eliminating sequences with low qualities [25]. Using
SILVA Incremental Aligner (SINA) implemented in the Mothur
software, we aligned qualified sequences to bacterial reference set
identified from the SSURef database [26], and removed chimeric
sequences by ChimeraSlayer [27]. We removed one outlier with a
very low sequence count and microbial diversity. Then, we
rarefied all the other samples by randomly sampling 15,951
sequences from each sample ten times in order to match the
sequence numbers across samples. Either normalized sequence
counts from individual subsamples or the average counts of ten
subsamples were used for further analyses, as indicated in text for
each analysis. To obtain the operational taxonomic units (OTUs),
we clustered the sequencing readouts at 90, 95, and 97% similarity
with UCLUST algorithm [28], which are roughly equivalent to
the taxonomic terms of family, genus, and species, respectively.
We used the Mothur software to obtain rarefaction curves and
ecological indices of Chao1 estimator and Shannon diversity/
richness [25]. We measured phylogenetic diversity (PD) index by
using Quantitative Insights Into Microbial Ecology (QIIME)
software package [29]. We classified sequences by the RDP
Classifier software at the 50% and 80%-confidence threshold for
sequence length longer than 200 basepair (bp) and 250 bp,
respectively [30]. We also performed the phylogeny-based metric
UniFrac analysis in order to evaluate the distribution of Prevotella
species [31]. Detailed analysis pipeline is provided in the
Supporting information (Text S1).
Quantitative Real-time PCR Analysis
We performed 16S rDNA-targeting quantitative real-time PCR
(qPCR) with triplicate PCR reactions in an Eppendorf Realplex
4S RealCycler. For Prevotella species, we constructed a seven-point
standard curve by using genomic DNA of Prevotella copri
(DSM18205). The PCR reagent mixture for each reaction was
20 mL consisting of 8 mL of 2.56 SYBR Premix Ex Taq Mix
(Takara Bio Inc, Japan), 1 mL of 10 mM Prevotella-specific each
forward and reverse primers [32], 2 ul 10-fold diluted DNA as a
template, and 8 mL PCR grade water. The PCR amplification was
conducted with initial 10 minute denaturation at 95uC, followed
by 35 cycles of denaturation (95uC for 15s), and annealing/
Autism-Associated Differences in Gut Microflora
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extension (60uC for 60s). For general bacteria, we performed
qPCR following the protocols described in Ziv-El et al. [33].
Statistical and Data Analysis
Statistical tests and classifications were done by Python (SciPy
stats library), and R programming (p.adjust for multiple testing
correction; glm for logistic regression; the glmperm package for
permutation test for regression [34]; the randomForest package for
Random Forests classification [35]). Hierarchical clustering
(average linkage) was performed with the Biopython package,
and clustergrams were generated by the Reportlab package for
Python (ver.2.6.5). Receiver operating characteristics (ROC)
curves and the area under the ROC curve (AUC) values were
obtained using the caTools package in R. PCA was performed
using the prcomp function (scaled and centered) in R, from which
the coordinates for genus and samples were obtained. Canonical
correlation analysis (CCA) and permutation test were conducted
by using the CCP package in R.
Results
Subject Characteristics
We collected stool samples from neurotypical and autistic
subjects (n = 20 each after gender balancing), with the mean ages
(6 SD) of 8.3 (64.4) and 6.7 (62.7) years, respectively (Table 1
and Dataset S1). To estimate the severity of GI symptoms, we
surveyed 6 categories of GI Severity index (6-GSI) (Table 1). As
previously reported, all autistic subjects had some degrees of GI
disorders [4]. However, when the severity of GI problems was
compared with autism severity, the 6-GSI scores did not have
strong correlations with any index for autistic symptoms, including
the ADOS (Pearson/Spearman rank correlation coefficient
r =20.33/0.28), the ATEC (r = 0.25/0.26), and the PDD-BI
(r = 0.15/0.09). We also found no statistical significance (Fisher
transformation and permutation tests P.0.05, Table 2).
Autism-associated Changes in Intestinal Microbial
Diversity
Maintaining sufficient bacterial richness and diversity is
important for providing gut microbiota with functional redundan-
cy, adaptability, and thus systematic robustness against environ-
mental challenges [36]. With a total of 987,801 qualified
sequences, we rarified each sample at 15,991 reads in order to
estimate bacterial richness and diversity (Table S1). Rarefaction
curves showed that neurotypical individuals had a higher number
of observed bacterial species than autistic individuals (Figure 1A
and Figure S1). As an alternative method to estimate the richness,
we employed the nonparametric Chao1 estimator in various levels
of OTU clustering. Similar to the rarefaction data from observed
OTUs, the neurotypical group had significantly higher number of
estimated OTUs (Figure 1B and Table S2A), which indicates that
the neurotypical group had higher bacterial richness than the
autistic group. To estimate microbial diversity, we employed two
ecological indices: Shannon and Phylogenetic Diversity (PD). First,
Shannon measurements showed a similar trend to the Chao1
estimator, but without statistic significance (Table S2B). The
Shannon index combines both bacterial richness and evenness.
The similar microbial evenness between samples (Table S2C)
offset the significance of bacterial richness when we calculated the
Shannon index. Different from the Shannon index, the PD index
incorporates the concept of phylogenetic distinctiveness and is
sensitive to species relatedness by summing the tree-branch length
present in each subject of a phylogenetic dendrogram [37]. The
PD index revealed that the neurotypical group harbored more
diverse gut microbiota than the autistic group did (P,0.05 by one-
tailed Mann-Whitney test in Figure 1C and Table S2D). In
addition, we also evaluated correlation between bacterial richness/
diversity and the severity of GI problems within the autistic group,
and bacterial richness was negatively correlated with GI severity
(Table S3). Taken together, these analyses suggest that the
presence of autistic symptoms and their correlated GI problems
are linked with reduced richness and diversity of gut microflora,
which results in a decrease in microbial redundancy and alter the
physiological functionality and microbial GI robustness in children
with ASD.
To investigate if autism-linked microbiome changes were
associated with other variables, such as general demographics
and special diets, we first performed multivariate analyses. Our
results indicate that age, gender, and diet were not significant
factors determining ecological indices (P.0.05) (Table S4), but
Chao1 estimator was most significantly correlated with autism
status (P,0.05) (Table 3 and Table S4). We also conducted
canonical correlation analysis (CCA) followed by permutation-
based non-parametric significance tests. As shown in Table S4C,
the combined profiles of diversity indices were not confounded by
demographics and/or diet patterns (P.0.05). Multivariate anal-
yses and CCA results show that reduced richness in children with
autism was not due to demographics or special diets.
Table 1. Summary of subject characteristics.
Subject characteristic Neurotypical Autistic
Total # participants 20 20
Male/Female 17/3 18/2





# of subjects using GF/CF diet 1 5
# of subjects using nutritional supplements 8 13
Probiotics (per week) 1.662.6 3.363.4
Seafood (per week) 0.460.5 1.262.3
Detailed information including GI severity, autistic severity indices, and diet
survey is attached in the Dataset S1.
doi:10.1371/journal.pone.0068322.t001
Table 2. Correlations between the severity of GI problems
and autism severity indices.
Age ADOS PDDBI ATEC
Pearson (r value) 20.147 0.33 0.145 0.252
P1/P2 0.55/0.74 0.17/0.08 0.58/0.29 0.31/0.16
Spearman rank (r
value)
20.141 0.277 0.089 0.257
P1/P2 0.57/0.73 0.25/0.12 0.74/0.37 0.30/0.16
Pearson and Spearman rank correlation between GI severity scores with autism
severity (P1: Fisher transformation, P2: permutation test).
doi:10.1371/journal.pone.0068322.t002
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Autism-associated Changes in Gut Microflora at Phylum
Level
For detailed taxonomic analyses, individual sequences were
classified by the RDP classifier [30], which assigned approximately
97% of total sequences to 15 known phyla. Firmicutes and
Bacteroidetes were the two most dominant phyla, as previously
reported by many studies [38], and the phyla Proteobacteria,
Verrucomicrobia, and Actinobacteria were also relatively abundant
(Figure S2). These five phyla comprised an average of 97.2% of
total classifiable sequences across samples. Comparison of mean
abundances between groups by the Student’s t-test showed that the
phyla Proteobacteria and Verrucomicrobia were more abundant in
neurotypical than autistic groups, respectively, but without
statistical significances after correction for multiple testing (Table
S5). Since the abundance data were not normally distributed and
contained a large fraction of zero values, we employed the non-
Figure 1. Comparison on bacterial richness and diversity between neurotypical and autistic children. (A) Rarefaction curves showing
unique OTUs at the 95% threshold (a box graph at the rarefied sequence number), comparison of (B) Chao1 estimators and (C) phylogenetic diversity
(PD) index between neurotypical (blue-colored box) and autistic (red-colored box) groups at different similarity thresholds (*: P,0.05, **: P,0.01 by
one-tailed Mann-Whitney test).
doi:10.1371/journal.pone.0068322.g001
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parametric Mann-Whitney test, which was used as the main
statistical test for comparisons throughout this study. The tests
showed that there was no significant difference in the relative
abundance of individual phyla between the two groups.
Autism-associated Changes in Gut Microflora at the
Genus Level
Among 214 genera identified by the RDP classifier, the genera
Bacteroides, Faecalibacterium, Bifidobacterium, Akkermansia, and Subdoli-
granulum were the top 5 most abundant genera in both neurotypical
and autistic groups. The 5 genera comprised 40% and 56% of
total sequences, respectively (Figure 2A and Table S6). Interest-
ingly, the genus Akkermansia was present at very high levels in
several autistic subjects, representing up to 59% of all sequences,
and the prevalence in those samples contributed to low diversity
(Figure S3).
The mean abundance of each genus was compared between
groups by the Student’s t-test and Mann-Whitney test (Table S7
and Table S8). The Mann-Whitney test with multiple testing
correction showed that unclassified Veillonellaceae and Prevotella were
significantly more abundant in the neurotypical group than in the
autistic (adjusted P= 0.04, Table S8, Figure 2B). In addition, with
marginal statistical significances, abundance of Coprococcus and
unclassified Prevotellaceae were also higher in neurotypical samples
(adjusted P= 0.06, Table S8, Figure 2B). To verify our interesting
results for Prevotella, we performed qPCR and confirmed the
reduced abundance in autistic children (Mann-Whitney test
P = 0.0002, Figure 2C). In order to measure how correctly the
relative abundance of each genus could classify two groups of
samples, we employed the ROC curve, which is closely related to
the Mann-Whitney test and commonly used to evaluate classifi-
cation performance of potential biomarkers. The performance of a
given binary classifier can be evaluated by measuring the AUC
that depicts true versus false positive rates, where an AUC value of
0.5 corresponds to random classification and a value of 1.0
corresponds to perfect classification. The above-mentioned genera
(unclassified Veillonellaceae, Prevotella, and Coprococcus together with
Lactobacillus) showed the highest AUC values among all genera, up
to 0.829 (Figure 2D and Table 4). We also obtained high AUC
values from parallel classifiers. Using six of the top ten genera in
terms of AUC, we constructed a logistic regression classifier and
measured its predictive capability using leave-one-out cross-
validation. The cross-validation AUC was 0.839, and inclusion
of age and gender into the logistic regression classifier did not
improve predictive performance. We also constructed a classifier
using Random Forests technique, and observed a similar
performance (cross-validation AUC=0.837). The AUC values
from above classifiers were highly comparable to those of known
biomarkers of many clinical disorders, e.g., urine biomarkers for
drug-induced kidney injury [39] and blood-based markers for
myocardial infarction [40].
In addition, we also performed permutation-based tests on
multivariate regression models to assess whether GI problems or
other clinical factors such as age, gender, dietary intakes, and
autism severity indices had any effect on the relative abundance of
the top ten genera generating the highest AUC values. Tests on all
samples showed that age, gender, and dietary intakes were not
significantly associated with the genus abundances (Table S4A),
but the autistic status turned out to be the most significantly
correlated factor with the abundances of these genera, especially
with unclassified Veillonellaceae, Prevotella, and Coprococcus (P,0.05 in
Table 5 and Table S4A). A mantel test (CCA) also supported that
age, gender, ethnicity, and dietary intake, when tested separately
or in combination, were not significantly correlated with the
abundance profile of the ten most differentially present genera
between the subject groups (P.0.1 in Table S4C). Furthermore,
within the autistic group, we did not observe any significant
correlation between age, gender, severity of GI symptoms, as well
as autistic indices, and the differentially present genus-level
abundances (Table S4B). Together, these multivariate analyses
demonstrate that there is a statistically significant correlation
between the presence of autistic symptoms and the genus-level
abundances and that severity of GI symptoms is not a significant
predictor of these microbial changes among autistic children.
Table 3. Permutation-based tests on univariate and multivariate regression models with the autistic status and microbial diversity
indices.





t-test Mann-Whitney Coef P SE Coef P SE
Chao 97% 0.014 0.008 0.00 0.017 0.004 0.00 0.012 0.003
95% 0.010 0.008 0.00 0.018 0.004 0.00 0.011 0.003
90% 0.013 0.010 20.01 0.028 0.005 20.01 0.008 0.003
Shannon 97% 0.120 0.080 20.62 0.202 0.013 21.29 0.075 0.008
95% 0.295 0.120 20.25 0.598 0.016 20.60 0.310 0.015
90% 0.420 0.100 20.09 0.847 0.011 20.29 0.583 0.016
Shannon-even 97% 0.250 0.140 23.53 0.494 0.016 210.2 0.147 0.011
95% 0.460 0.210 0.40 0.922 0.008 22.89 0.568 0.016
90% 0.350 0.380 1.12 0.702 0.014 20.41 0.905 0.009
PD 97% 0.062 0.031 20.03 0.097 0.009 20.04 0.151 0.011
95% 0.039 0.021 20.04 0.066 0.008 20.05 0.102 0.010
90% 0.018 0.021 20.11 0.031 0.005 20.13 0.066 0.008
(Coef: coefficient from linear regression, P: P value from permutation likelyhood ratio test for generalized linear model, SE: standard error for P value).
doi:10.1371/journal.pone.0068322.t003
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Species-level Analyses of Prevotella
A majority of 16S rDNA-based metagenomic analyses have
been done at a genus level. However, the observed abundance
profile of any given genus may represent the sum of heterogeneous
species and/or strains, which can lead to a less accurate
interpretation. Therefore, we investigated whether we could
Figure 2. Distribution of 39 subjects based on relative abundance. (A) The top 10 most abundant genera, (B) 4 most differentially abundant
genera (Red-colored box: autistic children, blue-colored box: neurotypical children), (C) the genus Prevotella obtained by qPCR analysis (Red-colored
box: autistic children, blue-colored box: neurotypical children), and (D) receiver operating characteristics (ROC) curve of the 4 genera that have the
highest area under curve (AUC).
doi:10.1371/journal.pone.0068322.g002
Table 4. Top 10 genera generating the highest area under curves in a receiver operating characteristics curve.
Mann-Whitney Median (25%/75%)
Family. Genus AUC P P adj. Neurotypical Autistic
Veillonellaceae.unknown_genus 0.829 0.000 0.039 0.04(0.01/0.21) 0(0/0.01)
Prevotellaceae.Prevotella 0.809 0.001 0.039 0.06(0.01/0.67) 0(0/,0.01)
Lachnospiraceae.Coprococcus 0.800 0.001 0.062 0.03(0.02/0.05) 0.01(0/0.01)
Lactobacillaceae.Lactobacillus 0.771 0.003 0.096 ,0.01(0/,0.01) 0.01(,0.01/0.04)
Prevotellaceae.unknown_genus 0.754 0.002 0.062 ,0.01(0/0.02) 0(0/0)
Alcaligenaceae.Sutterella 0.746 0.004 0.096 0.06(0/0.18) 0(0/0)
Lachnospiraceae.Roseburia 0.746 0.009 0.139 0.06(0.03/0.18) 0.02(0.01/0.05)
Porphyromonadaceae.Butyricimonas 0.712 0.007 0.139 0.01(0/0.09) 0(0/0)
Eubacteriaceae.Eubacterium 0.709 0.026 0.277 0.03(0.02/0.10) 0.13(0.05/0.25)
Prevotellaceae.Paraprevotella 0.703 0.009 0.139 ,0.01(0/0.35) 0(0/0)
A highest area under curves (AUC) value of 0.5 indicates no predictive, while an AUC of 1 indicates perfect ability to predict.
doi:10.1371/journal.pone.0068322.t004
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obtain in-depth inference from the sub-genus level analyses.
Among fully classified genera, Prevotella showed the most significant
differences between the sample groups by various statistical tests
(Figure 2D, Table 4, and Table S8). In addition, indicating the
physiological importance, a series of recent metagenomic studies
suggests that Prevotella is a key genus in determining gut
microbiome profile [41,42]. Thus, we decided to further
investigate Prevotella at a sub-genus level. First, all sequence reads
that were classified by RDP as the genus Prevotella were re-classified
into discrete OTUs at a 95% similarity level by UCLUST. The 22
identified OTUs were then clustered based on their relative
abundance across samples (Figure 3A). Noticeably, while the other
OTUs showed a scattered distribution across both groups, a major
cluster of 16 OTUs was exclusively present in neurotypical
samples (Figure 3A, in the green box). In order to see if the cluster
of 16 OTUs represented any known species, we combined the 16
OTU sequences with 16S rDNA sequences of 42 known type-
cultured Prevotella species and performed a phylogenic analysis by
multiple alignments. The dendrogram in Figure 3B shows that 16
Prevotella OTUs had higher sequence similarities to Prevotella copri
that was reported as the most prevalent Prevotella species in the gut
of North American population [43]. When we cross-matched the
OTUs between two independently generated clusters (i.e. based on
their relative abundance vs. sequence similarities), all 16 OTUs in
the major cluster identified in Figure 3A were mapped to the
sequence cluster that contained P. copri (Figure 3B, in the green
zoomed box). With these Prevotella copri-like 16 OTUs, we also
performed a weighted UniFrac analysis and observed distinct
clustering patterns between neurotypical and autistic groups
(Figure 3C). In addition, analyses on the co-occurrence and co-
exclusion network demonstrated that the loss of Prevotella copri-like
OTUs in autistic samples could result in a major reconfiguration
as well as a reduced complexity in the intestinal microbial
ecosystem (Figure S4). Taken together, these data strongly showed
that autistic children have very low levels of the Prevotella copri-like
phylotype in their GI tracts and that this phylotype is more
frequently found in neurotypical children who have more diverse
and robust microbial consortia.
Autism-associated Changes in Microbial Community
Profile and Gut Enterotypes
Like other environmental microbial ecosystems, human intes-
tinal microflora is distinctively shaped by diverse microorganisms
and their mutual interactions. Therefore, autism-related microflo-
ra alterations could be found at the level of community rather than
at the individual microbe level. In an effort to identify the
systematic differences in microbial communities between neuro-
typical and autistic groups, all genera were hierarchically clustered
based on their relative abundance across samples (Figure S5).
While the majority of clusters showed no apparent difference
between the groups, one cluster of 11 genera that included
Prevotella was, in general, at a greater abundance in neurotypical
samples (Figure 4A, green box). In addition, these genera shared a
similar pattern, especially within neurotypical samples, indicating
a coherent relationship among them. Interestingly, we also noticed
that another cluster enriched in Enterobacteriaceae (Figure 4A, red
box) displayed a negatively correlated pattern to the Prevotella
cluster within the neurotypical group (Pearson/Spearman rank
correlation coefficient r =20.52/20.67, Fisher transformation
test P= 0.02/0.001, and permutation test P= 0.0002/0.0008).
However, we did not observe an increase of the Enterobacteriaceae
cluster in autistic children despite the significant decrease in
Prevotella; suggesting that the community-wide interrelationship of
gut microbiota was altered in autistic children.
Recently, global profiles of the human gut microbiome were
examined to identify central components of the microbial
community [41,42]. Notably, Prevotella was proposed as one of
the three main microbes representing the human gut microbiome,
namely enterotypes [41]. Further, the ratio gradient between
Prevotella and Bacteroides was reported to be a good ecological metric
for characterizing gut microbiota in adults [42]. Therefore, given
that the presence as well as abundance of Prevotella was the main
difference between neurotypical and autistic groups, we tested
whether any systemic change in the gut microbiome profile was
associated with autism in relation to the enterotype and Prevotella/
Bacteroides gradient. First, we performed a principal component
analysis (PCA) on all 39 samples with the relative abundance of 16
selected genera (Table S9) that were reported in the co-occurrence
network of Arumugam et al. [41]. Although the PCA analysis did
not show three clearly discrete groups with the core genera (i.e.
Table 5. Permutation-based tests on univariate and multivariate regression models with the autistic status and top 10 genera
generating the highest AUC.
Univariate Multivariate
Family. Genus Coef P SE Coef P SE
Veillonellaceae.unknown_genus 20.36 0.000 0.000 20.53 0.002 0.001
Prevotellaceae.Prevotella 20.19 0.000 0.000 20.17 0.001 0.001
Lachnospiraceae.Coprococcus 20.44 0.000 0.000 20.56 0.001 0.001
Lactobacillaceae.Lactobacillus 0.05 0.171 0.012 0.02 0.742 0.014
Prevotellaceae.unknown_genus 20.03 0.060 0.008 20.06 0.085 0.009
Alcaligenaceae.Sutterella 20.04 0.021 0.005 20.08 0.034 0.006
Lachnospiraceae.Roseburia 0.00 0.244 0.014 0.00 0.494 0.016
Porphyromonadaceae.Butyricimonas 20.07 0.087 0.009 20.05 0.297 0.014
Eubacteriaceae.Eubacterium 0.02 0.071 0.008 0.01 0.787 0.013
Prevotellaceae.Paraprevotella 20.03 0.017 0.004 20.06 0.004 0.002
(Coef: coefficient from linear regression, P: P value from permutation likelyhood ratio test for generalized linear model, SE: standard error for P value).
doi:10.1371/journal.pone.0068322.t005
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Prevotella, Bacteriodes, and Ruminococcus), we observed that Prevotella,
Bacteriodes, and Ruminococcus were among the main contributors of
the first and the second principal components (Table S10). When
the frequencies of these pre-defined enterotypes were compared
between groups, the Prevotella-rich enterotype was absent in the
autistic group, while neurotypical samples showed an even
distribution among the three enterotypes (Figure 4B). We also
examined whether autistic subjects had different trade-off patterns
between Prevotella and Bacteroides at the genus level, and observed
that distributions of autistic and neurotypical groups were clearly
distinguishable by the Prevotella/Bacteroides gradient (Figure 4C). In
summary, these data demonstrate that the autistic population is
associated with a gut microbial community profile that is distinct
from that of a representative human population.
Discussion
Given the crucial role of gut microorganisms in maintaining GI
health, increasing evidence of more frequent occurrence of GI
problems in autistic children strongly implies a link between
autism and gut microbiota. Although the direction of causality
among interconnected pathophysiological factors (e.g., autistic
symptoms, diet patterns, GI symptoms, and gut microbiome
profile) is still unclear, it is important to identify systemic
microbiome changes and specific microorganism(s) that can be
targeted for diagnosis as well as for treatment of autism-related GI
problems and possibly other autistic symptoms. As a first step to
reach this long-term goal, we discovered several key differences.
First, autistic children tend to have a less diverse gut microbiome.
Secondly, several individual genera, most notably Prevotella, are
found at significantly lower abundances in autistic children. Lastly,
there are autism-associated global changes in intestinal microbial
community.
In our dataset, autistic samples displayed relatively low
microbial richness and diversity, especially when the relatedness
or phylogenetic distinctness was conjointly considered with
abundance for diversity estimation, such as the PD index (Table
S2) [37,44]. Higher diversity of gut bacteria may allow better
microbial integrity and the ability to protect the human intestine
from environmental stresses such as intake of pathogenic gut
microbes [45]. De Filippo et al. [46] observed higher diversity of
gut bacteria in rural African children than European children,and
hypothesized that the fiber-rich diet of African children provided
greater resistance to GI disorders, such as diarrhea than low-fiber
diet of European children. A metagenomic study by Qin et al. [47]
found 25 percent fewer genes in the gut of patients with irritable
bowel syndrome than in healthy controls. In contrast, Finegold
et al. [14] found a higher microbial diversity in autistic children
and suggested that an increase of pathogenic bacteria might
worsen autistic symptoms.
Discrepancies among high-throughput 16S rDNA sequencing
studies are common and can be resulted from several reasons, such
as sample source (e.g., feces vs. mucosal biopsy), uneven coverage
of microbes by different PCR primers, and the number of
sequence reads. In theory, based on our in silico simulation of 16S
rDNA-based PCR on entire microbiome, commonly used primer
sets for each variable region covered only 40 to 80% of known
genera (unpublished data). Moreover, the source of samples may be
an important contributor for the discrepancies. For example,
Finegold et al [14] reported a decreased Firmicutes to Bacteroidetes
ratio in autistic fecal samples, whereas Williams et al [48] observed
an opposite trend in ileum and cecum biopsy samples from
neurotypical children than those from autistic children, both with
GI problems. However, we observed no significant difference of
Bacteroidetes and Firmicutes between neurotypical and autistic
children. Additionally, analysis of biopsy samples showed that
the genus Sutterella in the Alcaligenaceae family was predominant in
autistic children with GI problems compared to neurotypical
children with GI problems [21]. We, however, observed that
Sutterella was slightly less abundant in fecal samples from autistic
children compared to the neurotypical ones (adjusted P=0.096,
Table 4). In addition to the differences in the experimental setting,
the type and stringency of statistical tests, such as consideration of
false discovery rates for multiple testing conditions, might affect
the interpretation of data.
Among fully classified genera in our study, Prevotella showed the
most significant difference in relative abundance between autistic
and neurotypical subjects. Prevotella is increasingly gaining atten-
tion as a commensal microbe in the human large intestine because
of its ability to degrade a broad spectrum of plant polysaccharides
[49]. Prevotella species were highly prevalent in African children
whose diet is rich in grains [46], implying not only that Prevotella
plays a key role in digesting carbohydrate-rich food, but also that
diet patterns can affect the abundance of Prevotella in human gut.
Supporting these notions, Wu et al. [49] recently reported that
carbohydrate-based diets shifted intestinal microbiota towards the
Prevotella-rich enterotype. Interestingly, autistic children are known
to have significant deficiencies in dissacharide metabolism, for
example, a low level of lactase activity in upper GI tract [48,50].
Williams et al [48] noted that unabsorbed mono- and disaccha-
rides may enter into the large intestine and cause the imbalance of
gut enviroment, where mono- and disaccharides fermenters may
outcompete polysaccharide degrading Bacteroidetes species, such as
Prevotella. Prevotella species also have essential genes for biosynthesis
of vitamin B1 [41], which was reported to mitigate ASD symptoms
[51]. Similar to our observation, Finegold et al [14] also recorded
the depletion of Prevotella in autistic children in contrast to its
prevalence in sibling controls, but no further discussion with
statistical analysis followed this observation. A significantly lower
abundance of the Prevotella cluster in autistic children could be
linked to a low carbohydrate diet, however, autistic and
neurotypical children generally consume comparable amounts of
carbohydrate and fiber [52]. In addition, Huws et al [53] reported
Prevotella as one of the dominant gut microbes enriched by fish oil
supplementation in the diet of ruminants. Fish oil is a precursor of
omega-3 fatty acids, which are beneficial for normal brain
development [54]. However, our data showed no significant
correlation between Prevotella abundance and the frequency of
seafood consumption. To clarify the relationship between diet
patterns and gut microbiota in autistic children, further studies
with detailed diet diaries are warranted.
In addition to its physiological functions as an individual
microbe, accumulating evidence supports a central niche of
Prevotella in maintaining the community structure of human gut
microbiome, as highlighted in studies by Yatsunenko et al [42]
and Arumugam et al. [41]. Generally agreeing with the enterotype
Figure 3. Comparison of gut microbiota within the genus Prevotella between neurotypical and autistic children. (A) Heat map profile
and dendrogram (A01-A19: autistic children, N01–N20: neurotypical children). A red, orange, and blue scale bar represents scores of autistic
symptoms, GI problems, and a log scale of the percentile abundance from a total bacteria, respectively. (B) Phylogenetic tree within the genus
Prevotella. (C) The weighted UniFrac analysis with Prevotella copri-like 16 OTUs. Jackknife counts over 50 out of 100 are shown.
doi:10.1371/journal.pone.0068322.g003
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Figure 4. Genus level comparison of gut microbiota between neurotypical and autistic children. (A) Heat map profile and dendrogram of
all identified genera (A01-A19: autistic children, N01–N20: neurotypical children). A red, orange, and blue scale bar represents scores of autistic
symptoms, GI problems, and a log scale of the percentile abundance from a total bacteria, respectively. (B) Principal Component Analysis at the genus
level from the autistic and neurotypical children. Blue- and red-, and black-colored dots represent neurotypical, autistic samples, and 16 selected
genera, respectively. Three genera representing enterotypes (23) were identified in bold. (C) The gradient of Prevotella and Bacteroides through
neurotypical and autistic children (*: P,0.05 by Mann-Whitney test).
doi:10.1371/journal.pone.0068322.g004
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study [41], we observed similar interrelationships between Prevotella
and its neighboring bacteria in our co-occurrence network. For
example, the Prevotella-cluster in Figure 4A contains unclassified
Veillonellaceae, Coprococcus, Desulfovibrio, and Oscillibacter. Unclassified
Veillonellaceae genus was not dominant in either neurotypical or
autistic groups, but turned out to be one of the most significantly
different genera between the two groups (Figure 2D). Most
members of the family Veillonellaceae (for example, Veillonella and
Megasphaera) ferment lactate [55,56], which may explain a potential
metabolic link between Veillonella and Prevotella as both genera
Veillonella and Prevotella also appeared in the co-occurrence network
[41]. Other studies show that the abundance of the family
Veillonellaceae increased when polydextrose and soluble corn fiber
were part of an adult diet [57]. However, in equine large
intestines, abundance of Veillonellaceae remained constant even with
diets with increased levels of sugar and starch [58]. Coprococcus
species are also fermenting bacteria, which mainly produce
butyrate [59,60]. Further implying a potential collaborative
physiological function of the Prevotella cluster as a group,
Arumugam et al. [41] speculated that Desulfovibrio species work
synergistically with Prevotella species to degrade mucin. In addition,
Desulfovibrio, Prevotella, and Oscillibacter can utilize microbial
exopolysaccharides synthesized by Bifidobacterium to produce
short-chain fatty acids in the human intestine [61]. Finegold et al
[14] claimed that Desulfovibrio was significantly more abundant in
autistic children compared with control children. However, they
used a less stringent statistical testing approach in which no
multiple testing correction was performed to control false
discovery. In addition, the inconsistent observation on Desulfovibrio
can be partly explained by different primer sets for pyrosequenc-
ing. We observed that the relative abundance of Desulfovibrio was
not significantly different between neurotypical and autistic groups
after multiple testing correction (Table S8), but its co-occurrence
with other genera in the Prevotella cluster may suggest a potentially
beneficial physiological role in metabolism, in contrast to the
pathogenic role speculated by Finegold et al [62].
As previously reported [41,46], we observed an Enterobacteriaceae-
rich cluster containing potentially pathogenic bacteria such as
Salmonella, Escherichia/Shigella, and Citrobacter [63]. The Enterobacte-
riaceae cluster displayed an opposite trend to the Prevotella cluster
among the neurotypical subjects (Figure 4A). De Filippo et al. [46]
suggested that suppression of pathogenic Escherichia/Shigella by
Prevotella might result in a lower incidence of GI disorders among
African children. Interestingly, unlike within the neurotypical
group, we did not observe this negatively correlated relationship
between the two clusters within the autistic group in which both
groups of bacteria were found at very low levels. This suggests a
substantial change in the balance of the gut microbiome in autistic
children.
Since all autistic subjects in this study had certain degrees of GI
problems, it is possible that the observed microbial differences are
associated with the presence of GI symptoms. However, the GI
indexes were not correlated with the changes in microbiome
profiles among autistic children (Table S4). Moreover, the balance
between three enterotypes appeared to be maintained even in the
presence of inflammatory bowel disease and obesity [41] that are
known to profoundly alter gut microbiome [64,65]. Moreover, a
recent study reported that irritable bowel syndrome (IBS) subjects
had a different pattern of enterotypes, where the Ruminococcus-rich
enterotype was highly dominant [66], whereas autistic samples
contained evenly distributed Ruminococcus-rich and Bacteroides-rich
enterotypes (Figure 4B). Interestingly, Rajilic-Stojanovic et al. [66]
also reported that IBS samples had moderately reduced levels of
several Prevotella species (P. oralis, P. ruminicola, and P. tannerae). In
agreement, these species were observed at slightly lower levels in
autistic samples than neurotypical ones in our study (Figure 3B).
However, an abundance of P. copri-related Prevotella species, such as
P. oulorum and P. paludivivens, was reduced in autistic subjects
(Figure 3) but not in IBS patients [66]. Therefore, distinct from
other GI disorders, autism-related GI disorders may be linked to a
unique shift in microbial balance, reflected by the absence of
Prevotella, especially the P. copri -like phylotype.
Despite its experimental versatility and well-established bioinfor-
matics resources for phylogenetic classification, 16S rDNA-based
metagenomic studies have an intrinsic limitation for biological
inference. Due to functional redundancy and crosstalk among
microbes [43], it is difficult to predict inclusive physiological impact
of microbiome changes simply by measuring presence/absence and
abundance of bacteria. Metabolic outcomes can be bioinformati-
cally estimated by overlaying the total gene content in genomes of
identified microbes onto known pathway information, as previously
attempted in metagenomic studies [41,42,49]. However, in order to
obtain an in-depth view on functional crosstalk between host and
microbial composition changes, more comprehensive data includ-
ing metatranscriptome, proteome, and metabolome are needed.
The long-term effect of enhanced antibiotics use is a potentially
important factor that has not been addressed in this and other
previous autism-related metagenomic studies. Studies focusing on
fecal metabolites and microbiota show that gut microbiota and its
diversity can be restored and stabilized within a month after
antibiotic treatments [67–69]. Therefore, in this study, we only
included subjects who had not taken any antibiotics at least within
a month prior to sample collection. Thus, we assumed that the gut
microbiota in the collected fecal samples had already recovered
and stabilized after recent or past antibiotic treatment. Notably, in
a recent paper by Dethlefsen and Relman [68], Prevotella, one of
the significant genera observed here, was re-established back to
pre-antibiotic levels within one month after ciprofloxacin treat-
ment. However, we cannot rule out the possibility that more
frequent exposure to antibiotics at earlier ages may perturb gut
microbiota for a longer term in autistic children [70] even though
autistic and neurotypical children take antibiotics at similar
frequencies after the age of three [8]. Further retrospective and
longitudinal studies are essential to accurately assess the long-term
influence of antibiotics use in relation to autism.
In summary, we demonstrated that autism is closely associated
with a distinct gut microflora that can be characterized by reduced
richness and diversity as well as by altered composition and
structure of microbial community. Most notably, we also
discovered that the genera Prevotella, Coprococcus, and unclassified
Veillonellaceae were significantly reduced in autistic children.
Unexpectedly, these microbial changes were more closely linked
to the presence of autistic symptoms rather than to the severity of
GI symptoms and specific diet/supplement regimens. Despite
limited information on the direction of causality among autism,
diet, GI problems, and microbiome profiles, the findings from this
study are stepping stones for better understanding of the crosstalk
between gut microbiota and autism, which may provide potential
targets for diagnosis or treatment of neurological as well as GI
symptoms in autistic children.
Supporting Information
Figure S1 Rarefaction curves to show sequencing
numbers and observed operating taxonomic units
(OTUs) obtained by UCLUST. Sequence similarity thresholds
at (a) 97%, (b) 95%, and (c) 90%.
(PDF)
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Figure S2 Relative abundance of gut microbiome at the
phylum level. Red boxes: autistic children, blue boxes:
neurotypical children.
(PDF)
Figure S3 Distribution of relative abundance of the
genus Akkermansia in 39 subjects. N: neurotypical, A:
autistic group.
(PDF)
Figure S4 Co-occurrence network at the 97% OTU level.
OTU pairs that show positive correlation (Pearson’s R .0.8)
among normal samples are presented as a network. The edge
colors represent correlation of each OTU pair among autistic
samples, as indicated in legend. Prevotella copri like OTUs and their
direct edges are highlighted in yellow and green, respectively, to
show the extent of network perturbation resulted from the absence
of the OTUs in autistic subjects.
(PDF)
Figure S5 Heat map profiles and dendrograms of all
identified genera. A01–A19: autistic children, N01–N20:
neurotypical children. The color represent averaged relative
abundances in a log scale from 10 random sub-samplings.
(PDF)
Table S1 Pyrosequencing data summary with the
number of a total sequence reads and qualified
sequence reads. Subject description: Neurotypical (N) and
Autistic (A) children.
(XLSX)
Table S2 Microbial diversity indices with OTUs ob-
tained by UCLUST (90, 95, and 97% similarity). (A)
Chao1 estimator, (B) Shannon diversity index, (C) Shannon
evenness index, and (D) Phylogenetic Diversity. (P-values were
obtained by one-tailed Student’s t-test and Mann-Whitney test.)
(XLSX)
Table S3 Correlation between microbial richness/di-
versity and severity of GI problems within the autistic
group. (A) Chao1 estimator, (B) Shannon diversity index, (C)
Shannon evenness index, and (D) Phylogenetic diversity. (P1 and
P2: P values from Fisher transformation and permutation test).
(XLSX)
Table S4 Permutation-based tests on univariate and
multivariate regression models between the autistic
status/demographic/diet patterns and microbial diver-
sity indices/top 10 genera with the highest AUC (A)
among all samples and (B) within autistic samples. The
coefficient for age, autism severity indices (ADOS, ATEK, PDD-
BI), and GI index are the log odds ratios of genus abundance for a
one unit change in the age, autism severity indices, and GI index,
respectively. The coefficient for gender is the log odds ratio of
genus abundance for males compared to females. P-values less
than 0.05 are indicated in bold characters. (Coef: coefficient from
linear regression, P: P value from permutation likelyhood ratio test
for generalized linear model, SE: standard error for P value). (C) P
values by permutation tests of canonical correlation analysis
(CCA).
(XLSX)
Table S5 Relative abundance (Median values (%) and
25/75 percentiles) of 15 phyla detected throughout all
subjects.
(XLSX)
Table S6 Top 20 abundant genera among 214 known
genera in neurotypical (N) and autistic (A) subjects. The
subject numbers (#N and #A) are counts of subjects that contain
corresponding genera in fecal samples. The average percentage of
each genus is indicated in the column ‘% Total.’
(XLSX)
Table S7 Genera presenting significant difference be-
tween neurotypical and autistic children by two-tailed
Student’s t-test results. Relative abundance is shown as
median values and 25/75 percentiles. Adjusted P values were
0.606 for all listed genera.
(XLSX)
Table S8 Genera presenting significant difference be-
tween neurotypical and autistic children by nonpara-
metric ranksum test (two-tailed Mann-Whitney test). Relative
abundance is shown as median values and 25/75 percentiles.
(XLSX)
Table S9 The list of bacterial groups that presented in
the co-occurrence networks of the enterotype study
(Arumugam et al. 2011)*. The genera in bold were used for our
PCA analysis. The rest of genera were not considered because of
no/little observation through our samples.
(XLSX)
Table S10 List of genera considered for principal
component analysis. Main contributors of the first and second
principal components are indicated in bold characters.
(XLSX)
Text S1 Supplementary Materials and Methods. Detailed
information includes subject recruitment and characteristics and
pyrosequencing analysis of community structure.
(PDF)
Dataset S1 Detailed information of metadata on the
survey of neurotypical and autistic participants. Meta-
data include GI severity, autistic severity indices, diet survey, and
relative abundances of gut microbiota at the genus level.
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